Immix Biopharma Inc
IMMX
Get informed when a big investor buys or sells
+ FollowMarket Cap$514.64M
Close$
$2.82
64.7% downside
Current Fair Value
64.7% downsideOvervalued by 64.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $514.64 Million |
|---|---|
| Enterprise Value | $290.15 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.89 |
| Beta | 0.11 |
| Outstanding Shares | 63,771,377 |
Return
| Return on Equity | -17.44% |
|---|---|
| Return on Assets | -16.69% |
| Return on Invested Capital | -18.11% |
Valuation & Multiples
| P/E Ratio | -10.75 |
|---|---|
| PEG | -14.43 |
| Price to Sales | - |
| Price to Book Ratio | 2.66 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -6.97 |
| Enterprise Value to Net Income | -8 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
September 2, 2026
EPS Estimate
$-0.21
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
November 6, 2026
EPS Estimate
$-0.19
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 22.63% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.00%▼ 88.36% |
|---|---|
| Total Invested | $8,615▼ 100.00% |
| Investors Holding | 3▼ 111.00% |
ESG Score
No data